Nuvo TSX:NRI is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo has three commercial products that are available in a number of countries Pennsaid , Pennsaid and the heated lidocaine/tetracaine patch. Pennsaid is sold in the U.S. by Horizon Pharma plc NASDAQ:HZNP and is available for partnering in certain other territories around the world. Nuvo manufactures Pennsaid for the global market and Pennsaid for the U.S. market at its FDA, Health Canada and E.U. approved manufacturing facility in Varennes, Qu bec.
Quote | Nuvo Research Inc (OTCMKTS:NRIFF)
Last: | $0.7475 |
---|---|
Change Percent: | 0.0% |
Open: | $0.7446 |
Close: | $0.7475 |
High: | $0.7475 |
Low: | $0.7446 |
Volume: | 3,000 |
Last Trade Date Time: | 01/01/2021 04:55:04 pm |
News | Nuvo Research Inc (OTCMKTS:NRIFF)
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Nuvo Pharmaceuticals' ([[NRIFF]] -0.6%), d/b/a Miravo Healthcare, wholly owned subsidiary entered into an exclusive license and supply agreement with Espoo, Finland headquartered Orion for the exclusive right to package, distribute, market and sell Suvexx in select E...
Message Board Posts | Nuvo Research Inc (OTCMKTS:NRIFF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...